SNHG12 and ovarian cancer: To further investigate the expression levels of SNHG12 in clinical ovarian cancer samples, we determined the levels of the SNHG12 which was significantly upregulated in ovarian cancer clinical samples compared to adjacent normal tissues (Figure 7A, p < 0.05), suggesting that SNHG12 might be the cause of ovarian cancer immune escape.